tirzepatide sleep apnea Can Zepbound Treat Apnea? What the FDA Says Tirzepatide for Obstructive Sleep Apnea

Average Weight Loss on Semaglutide In the main clinical trial that supported semaglutide's approval for weight management (the STEP 1 trial), adults who took the 2.4 mg weekly dose lost, on average, about 15% of their body weight over 68 weeks, compared with a much smaller amount in the placebo group

But "most" is not "all," and several specific populations may find genuine value in a sub-2.5 mg entry point

(Source: ASMBS, June 2025) A 2026 network meta-analysis of randomized controlled trials (30 trials, 20,015 patients) found metabolic/bariatric surgery achieved significantly greater reductions than GLP-1 receptor agonists in total weight loss (10.3 percentage points), BMI (4.5 kg/m), body weight (11.7 kg), waist circumference (12.6 cm), and HbA1c (0.5%) at under 104 weeks

No special apps or downloads required

Its available over-the-counter or with a prescription

MR-Egger intercept test and Cochrans Q statistic were utilized to assess pleiotropy and heterogeneity, respectively